Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_64e147e7d1db528d4e8e1696f336eba4 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-513 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00 |
filingDate |
2010-12-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2013-11-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2edaee6d1b9e45c570f77dd5d5eaf8e3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_83f1c09523d9a194291d66343a90bd51 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_907091a2aacfc23c4aeb9a5239b25c14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_46b676da326882a6d7eacb09796966bf http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7a61c6511d7c4f41090f55bbb367eed8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_faebac5a2b601b56efc1b368b600a847 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_37c9785c29a60ef37c40c42dd2414095 |
publicationDate |
2013-11-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
CN-102552103-B |
titleOfInvention |
Lamivudine solid dispersion, and preparation method, pharmaceutical composition and use of the dispersion |
abstract |
The invention relates to lamivudine solid dispersion and a preparation method and a use of the lamivudine solid dispersion. The lamivudine solid dispersion provided by the invention is prepared by using a methoxy-terminated polyethylene glycol-polylactic acid block copolymer and derivatives of the block copolymer, polylactic acid, polylactic acid-glycolic acid copolymer or polycaprolactone as carrier materials by a hot melting method. The preparation method of the lamivudine solid dispersion provided by the invention avoids use of an organic solvent. The lamivudine solid dispersion provided by the invention can be applied in subcutaneous injection or intramuscular injection for treating chronic hepatitis B. |
priorityDate |
2010-12-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |